Gregory Katz's Substack
Subscribe
Sign in
Home
Notes
Archive
About
Latest
Top
Are colonoscopies overrated or underrated for cancer screening?
A look at the NordICC trial
Jun 28
•
Gregory Katz, MD
April 2024
What's up with HDL?
In many ways, the story about HDL is simple: in general, having a higher level seems to be protective against heart disease, but raising that level with…
Apr 26
•
Gregory Katz, MD
Preventative stenting for high risk patients
When it seems to good to be true, it probably is
Apr 19
•
Gregory Katz, MD
Most doctors know very little about asthma treatment - Beyond Journal Club Podcast
The MANDALA trial teaches us about a common disease that's commonly mistreated
Apr 11
•
Gregory Katz, MD
35:00
Can Ozempic treat heart failure?
More from ACC
Apr 10
•
Gregory Katz, MD
Rethinking a post heart attack treatment
The annual American College of Cardiology (ACC) is just finishing up its annual conference in Atlanta.
Apr 8
•
Gregory Katz, MD
Andrew Huberman is Dr. Oz
Andrew Huberman is one of the biggest names in the world of wellness.
Apr 5
•
Gregory Katz, MD
March 2024
Does marijuana cause heart disease?
A deeper look at a study that just made news
Mar 29
•
Gregory Katz, MD
Should you worry about microplastics?
If you’re like me, you’ve heard about the alleged harms of microplastics over the past handful of years.
Mar 22
•
Gregory Katz, MD
January 2024
Why was I wrong about blood transfusions?
A look at the MINT trial
Jan 12
•
Gregory Katz, MD
December 2023
The year of Ozempic?
Ozempic, AI, and gene editing
Dec 28, 2023
•
Gregory Katz, MD
Holy crap - CRISPR is here
There’s big new stuff happening in the world of gene editing: a permanent cure for sickle cell disease through gene editing has just received FDA…
Dec 12, 2023
•
Gregory Katz, MD
Share
Copy link
Facebook
Email
Note
Other
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts